A carregar...
Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness
Background: When treatment-refractory schizophrenia shows an insufficient response to a trial of clozapine, clinicians commonly add a second antipsychotic, despite the lack of robust evidence to justify this practice. Objectives: The main objectives of the study were to establish the clinical effect...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
NIHR Journals Library
2017-09-01
|
Colecção: | Health Technology Assessment |
Assuntos: | |
Acesso em linha: | https://doi.org/10.3310/hta21490 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|